Oregon 2017 Regular Session Status: In Committee

HB 2386 — Relating to drugs; prescribing an effective date.

Last action — In committee upon adjournment.

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 2017 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Summary

Directs each manufacturer of certain types of drugs that are sold within this state to develop and implement drug take-back program for purpose of collecting from individuals and nonbusiness entities those types of drugs for disposal. Directs State Board of Pharmacy to administer Act. Requires manufacturers subject to Act to first submit plan for developing and implementing drug take-back program on or before December 31, 2018. Becomes operative January 1, 2018. Takes effect on 91st day following adjournment sine die.

Bill Text

We don't have the full text on file for this bill yet.

Read HB 2386 on the official Oregon source →

Action History

  1. In committee upon adjournment.

  2. Public Hearing held.

  3. Referred to Health Care with subsequent referral to Ways and Means.

  4. First reading. Referred to Speaker's desk.

Sponsorship breakdown

Export CSV (upgrade) →

0 sponsors · 0 co-sponsors · 90 not signed on

Sponsors (0)

None.

Co-sponsors (0)

None.

Not signed on (90)

90 members have not signed on to this bill.

Show all 90 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

public-safety environment healthcare
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB 2386 do?
Directs each manufacturer of certain types of drugs that are sold within this state to develop and implement drug take-back program for purpose of collecting from individuals and nonbusiness entities those types of drugs for disposal. Directs State Board of Pharmacy to administer Act. Requires manufacturers subject to Act to first submit plan for developing and implementing drug take-back program on or before December 31, 2018. Becomes operative January 1, 2018. Takes effect on 91st day following adjournment sine die.
What is the current status of HB 2386?
This bill died with 2017 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track HB 2386?
Track HB 2386 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 2386

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB 2386

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →